● Recruiting

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

Condition: Prostate Cancer · Lower Urinary Tract Symptoms · Sponsor: University of Kansas Medical Center

PhaseNA

Planned participants30

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

To determine if holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) and/or urinary retention alters the treatment course for patients concurrently diagnosed with prostate cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Jane Ledesma, BS · (913) 588-8721 · jledesma2@kumc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Kansas Health System

Kansas City, Kansas, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03802851